Of the twelve interventions that led to a statistically significant lower incidence of PTBs compared to controls, some observations currently seem to rely on weak evidence due to single, small or poor methodological quality trials (e.g., fetal fibronectin testing [18], bed rest for hypertension during pregnancy [39] and dietary magnesium supplementation[48]). The gene discussed is FN1; the disease is Hypertension.